Combination of 2′-Fluoroadenine and 5′-Methylthioadenosine Shows Therapeutic Potential in Variety of Cancers
PHILADELPHIA (August 14, 2018) — Warren Kruger, PhD, a professor of cancer biology at Fox Chase Cancer Center, recently published a study in the journal Cancer Research describing a promising new combination therapy approach to killing tumor cells while sparing healthy cells.